Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05832684 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date changed from estimate of Dec 2024 to Jul 23, 2024
    • Publications: 2 to 5
    v3
  2. Primary completion date: Dec 2028 to Dec 2024
    • Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 4 to 3
    • Publications: 1 to 2
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study was to evaluate the safety and efficacy of ZVS101e administered by subretinal injection in subjects with Bietti's crystalline dystrophy (BCD) and to select the optimal effective dose.
Trial Details
NCT Number NCT05832684
Lead Sponsor Chigenovo Co., Ltd
Conditions
(from sponsor)		 Bietti's Crystalline Dystrophy
Related terms Bietti Crystalline Dystrophy
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov